How do I buy Artiva Biotherapeutics (ARTV) stock?

You can purchase shares of Artiva Biotherapeutics (NASDAQ:ARTV) through any online brokerage.View our list of the best stock brokerages

Who are Artiva Biotherapeutics (ARTV) competitors?

Other companies in Artiva Biotherapeutics’s space includes: Macrogenics Inc (NASDAQ:MGNX), Tharimmune Inc (NASDAQ:THAR), Anixa Biosciences Inc (NASDAQ:ANIX), Connect Biopharma Holdings Ltd (NASDAQ:CNTB) and Elicio Therapeutics Inc (NASDAQ:ELTX).

What is the forecast, or price target, for Artiva Biotherapeutics (ARTV) stock?

Artiva Biotherapeutics has a consensus price target of $19.29.

What is the current price for Artiva Biotherapeutics (ARTV)?

The stock price for Artiva Biotherapeutics (NASDAQ: ARTV) is $4.8481 last updated January 15, 2026 at 9:20 AM EST.

Does Artiva Biotherapeutics (ARTV) pay a dividend?

There are no upcoming dividends for Artiva Biotherapeutics.

When is Artiva Biotherapeutics (NASDAQ:ARTV) reporting earnings?

Artiva Biotherapeutics does not have any upcoming earnings scheduled.

Is Artiva Biotherapeutics (ARTV) going to split?

There is no upcoming split for Artiva Biotherapeutics.

What sector and industry does Artiva Biotherapeutics (ARTV) operate in?

Artiva Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Artiva Biotherapeutics (ARTV) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the compan...

Comments